Description:
The CONTAK RENEWAL CD is an innovative medical device designed and manufactured by Boston Scientific Corp. This advanced tool pertains to the field of cardiology and its main purpose is to assist patients experiencing heart rhythm disorders, specifically ventricular tachycardia and fibrillation.
This state-of-the-art device is integrated with a Defibrillator (ICD) and Cardiac Resynchronization Therapy (CRT). The ICD aids in preventing sudden cardiac arrest due to dangerously fast heartbeats, and the CRT improves heart efficiency, enhances blood flow, and mitigates symptoms of heart failure.
Among its notable benefits, the CONTAK RENEWAL CD offers personalized therapy with its adaptive technology, meaning it adjusts its functioning based on an individual's unique heart condition. Additionally, it features an extended battery life, minimizing the frequency of replacement surgeries, therefore reducing potential risks and improving patient comfort.
The device's innovative capabilities, combined with the reliable reputation of Boston Scientific Corp., strongly position the CONTAK RENEWAL CD as a valuable tool in the management of heart diseases.
Description:
The CONTACK RENEWAL IS1/DR1 CRT-D is a cutting-edge medical device designed by Boston Scientific Corp. It plays an instrumental role in effectively managing heart rhythm disorders such as heart failure or arrhythmias. Its features stem from the innovative technological advancements made in the field of cardiac resynchronization therapy.
This revolutionary device is primarily used for detecting and correcting irregular heart rhythms by delivering minor electric shocks. In essence, the CONTACK RENEWAL IS1/DR1 CRT-D can help many patients resume a normal lifestyle by improving their heart's efficiency and overall functionality.
The primary benefits of the CONTACK RENEWAL IS1/DR1 CRT-D include:
With Boston Scientific Corp.'s strong emphasis on quality assurance and innovative design, the CONTACK RENEWAL IS1/DR1 CRT-D is a reliable and proven solution for facilitating effective cardiac resynchronization therapy.
... Read moreDescription:
The CONTAK RENEWAL 3 is a cutting-edge cardiac resynchronization therapy defibrillator (CRT-D) developed by Boston Scientific Corp. This FDA-approved device is designed to provide superior automaticity and advanced arrhythmia monitoring.
Primarily, CONTAK RENEWAL 3 is used to treat patients with advanced heart failure symptoms and reduced ejection fraction who remain symptomatic despite optimal drug therapy. It also serves those at high risk of sudden cardiac death due to previous ventricular arrhythmias or myocardial infarctions.
Benefits of CONTAK RENEWAL 3:
1. Ventilation Sensor: Monitors the patient's minute ventilation to naturally adapt to pacing rates based on metabolic needs.
2. SmartDelay™: An algorithm that proposes optimal AV/PV and VV delays to improve patient response to CRT.
3. Heart Failure Sensor Suite: Tracks physiological trends to aid in the management of heart failure patients.
4. Arrhythmia Management Features: Includes precise diagnostics for actionable insights, contributing to improved patient outcome.
Description:
The CONTAK RENEWAL is a technologically advanced medical device meticulously designed by Boston Scientific Corporation. It is a Cardiac Resynchronization Therapy Defibrillator (CRT-D) created to serve a dual function, acting as both a defibrillator and a pacemaker.
This device is equipped with the ability to both detect and correct dangerous rapid heart rhythms (arrhythmias), or fibrillations, by sending electrical impulses to restore the heart's normal rhythm. The CARDIAC RENEWAL is typically used for patients struggling with heart failure, mitigating symptoms, and improving the quality of life.
The CRT-D functionality ensures improved heart synchronization. This function assists in optimizing the heart's lower chambers' simultaneous beating, and hence, increases the efficiency of a failing heart. The combination of these two features allows the device to effectively manage heart conditions and potentially prevent instances of sudden cardiac arrest.
The CONTAK RENEWAL by Boston Scientific Corp. has proven to be an invaluable tool in the field of cardiovascular therapy, aimed at providing patients with a safer, more adaptable solution for managing heart conditions. With Boston Scientific's unwavering commitment to delivering innovative healthcare solutions, this device opens a new avenue towards reshaping patient experiences and improving heart failure therapy outcomes.
Description:
The CONTAK RENEWAL 3 is an advanced medical device that serves as a Cardiac Resynchronization Therapy Defibrillator (CRT-D). Developed by Boston Scientific Corp., this remarkable device is primarily designed to manage and regulate a patient's heart rhythm.
This Class III device functions by delivering therapeutic electrical impulses to the heart to treat symptoms associated with severe or life-threatening cardiac arrhythmias. The CONTAK RENEWAL 3 is especially beneficial to individuals struggling with advanced heart failure who are at risk of sudden cardiac death caused by ventricular arrhythmias.
One of the primary benefits of the CONTAK RENEWAL 3 is its capacity to monitor and pace both ventricles of the heart simultaneously. This facilitates efficient improvement in ventricular function and enhances the overall quality of patient life. This technologically advanced device also incorporates Heart Failure Sensor Suite technology, enabling improved overall disease management.
Another notable benefit is its longevity. The device's powerful battery provides an extended lifespan, reducing the frequency of replacement surgeries and ultimately delivering long-term reliability.
... Read moreDescription:
The CONTAK RENEWAL 3 by Boston Scientific Corp. is a state-of-the-art cardiac resynchronization therapy defibrillator (CRT-D) designed to offer a novel treatment for patients with heart failure.
Designed with sophisticated features, it could augment patient care and potentially improve quality of life through its advanced double technology. It pairs both cardiac resynchronization therapy (CRT) and defibrillation therapy, creating a robust device for both the regulation and correction of the heart rhythm.
This dual-chamber defibrillator can deliver an electric shock to the heart to restore normal rhythm when it detects life-threatening ventricular arrhythmias. Furthermore, it aids in optimizing the heart's pumping efficiency through its distinctive ability to re-coordinate the action of the right and left ventricles.
The CONTAK RENEWAL 3 is remarkable for its ability to customize therapy to individual patient needs, enhancing patient care and management. With the added capability for diagnostics and patient monitoring, it offers physicians important insights into their patients’ heart health and response to therapy over time.
In summary, the CONTAK RENEWAL 3 by Boston Scientific Corp. is a cutting-edge medical device, offering sophisticated technology for the provision and management of patient care in the context of heart rhythm disorders.
Description:
Boston Scientific Corp. introduces the CONTAK RENEWAL 3, CONTAK RENEWAL 3 HE, and CONTAK RENEWAL 3 RF — a cutting-edge series of cardiac resynchronization therapy defibrillators (CRT-D). These devices are designed to monitor, pace and, if necessary, deliver life-saving defibrillator therapy to patients suffering from heart failure.
Key Features and Benefits:
1. Cardiac Resynchronization: These devices help in the regulation of heart rhythms by resynchronizing the contractions of the heart's ventricles, thereby improving the efficiency of the heart.
2. Defibrillator Function: They have an inbuilt defibrillator function that provides immediate response during life-threatening arrhythmias, delivering an electric shock to restore a normal heart rhythm.
3. Continuous Monitoring: CONTAK RENEWAL devices continuously monitor the heart's electrical activity, allowing for immediate detection and response to abnormal rhythm.
4. Adaptive Pacing: The adaptable pacing feature adjusts pacing according to the patient’s physiological need, facilitating greater patient comfort and device longevity.
5. Patient Safety: Superior technology ensures a swift and effective response during cardiac events, enhancing patient safety.
6. Reduced Hospital Visits: These devices reduce the necessity for hospital visits due to their capacity for remote patient management and wireless data transmission.
Contak Renewal 3 devices by Boston Scientific Corp. thus excel at offering effective and proactive management for patients with heart failure, significantly improving their quality of life while ensuring utmost safety.
... Read moreDescription:
The CONTAK RENEWAL by Boston Scientific Corp. is an advanced Cardiac Resynchronization Therapy Defibrillator (CRT-D). It's a technologically progressive device that stands at the forefront of medical equipment used for cardiac care.
The CONTAK RENEWAL 3 is specifically designed to manage heart rhythms and reduce the risk of sudden cardiac arrest, a critical healthcare challenge faced by many patients with heart failure.
The exceptional benefits of the CONTAK RENEWAL 3 lie in its unique capabilities to both resynchronize the beating of the patient’s heart and garner the life-saving power of a defibrillator. This dual function makes it a reliable solution for patients suffering from heart failure with a reduced ejection fraction who are at risk for sudden cardiac arrest.
Its adaptive circuit technology allows personalized therapy and advanced energy management, ensuring the optimum performance and longevity of the device. Additionally, the CONTAK Renewal features Greenlight™ Confirmation - a proprietary safety system designed to provide an added layer of protection.
In sum, the CONTAK RENEWAL 3 serves as a leading-edge solution providing personalized cardiac care, giving clinicians an impactful tool, and patients a safer path towards recovery.
... Read moreDescription:
The CONTAK RENEWAL 3 RF is an advanced cardiac resynchronization therapy defibrillator (CRT-D), designed and manufactured by Boston Scientific Corp. Boasting state-of-the-art technology in cardiac healthcare, this device is essential for patients with heart failure who are prone to dangerous heart rhythms. Its key feature is to reinstate normal heart rhythm, thereby improving a patient's quality of life.
The primary position of this device is in aiding the heart to pump blood efficiently throughout the body. By providing real-time data, the CONTAK RENEWAL 3 RF allows physicians to monitor their patient's heart activity remotely. This capability ensures immediate medical intervention when necessary and provides valuable insights for personalized therapy adjustments.
The advanced shock reduction technology in CONTAK RENEWAL 3 RF aids in reducing inappropriate and unnecessary shocks, which contributes significantly to patient comfort and well-being. The device is highly robust and reliable, designed to deliver enduring performance.
In conclusion, the CONTAK RENEWAL 3 RF represents a revolution in CRT-D the rapy, combining functionality, patient comfort, and physician utility in one compact device.
... Read moreDescription:
The CONTAK RENEWAL 3 is a sophisticated medical device designed and manufactured by Boston Scientific Corp., a renowned name in the realm of medical technology. Serving as an advanced cardiac resynchronization therapy defibrillator (CRT-D), it is primarily used to manage heart rhythm disorders.
This cutting-edge CRT-D device provides a comprehensive solution for cardiac care, offering both heart rhythm management and defibrillator functionality. It helps heart chambers beat more synchronously, improving the heart's blood pumping efficiency, thereby benefiting patients with heart failure. Simultaneously, it maintains the capability to deliver a lifesaving shock should a lethal heart rhythm disorder occur.
Equipped with Amplia Quad CRT-D technology, the CONTAK RENEWAL 3 offers personalized therapy options, effectively adapting to the individual patient's needs. This involves ventricular and atrial arrhythmia therapies and advanced heart failure diagnostics. Those features significantly enhance medical professionals' ability to monitor and manage a variety of complex cardiac conditions, hence promoting patient safety and improving their overall quality of life.
With its multi-purpose functionality, the CONTAK RENEWAL 3 stands as a pivotal tool in comprehensive cardiac care, serving both the patient and the healthcare professional with precision and reliability.
Description:
The CONTAK RENEWAL is a sophisticated cardiac resynchronization therapy defibrillator (CRT-D) designed and manufactured by Boston Scientific Corp. This state-of-the-art device plays a crucial role in treating patients with heart rhythm disorders, specifically those suffering from heart failure.
The device is implanted beneath the skin and works by delivering electrical signals to orchestrate synchronized contractions of the heart’s chambers. This integral synchronization optimizes heart’s functionality and efficiency, significantly contributing to improved patient health and quality of life.
Key benefits of the CONTAK RENEWAL include:
Description:
The CONTAK RENEWAL is a highly advanced, innovative cardiac resynchronization therapy defibrillator (CRT-D) engineered by globally recognized healthcare technology leaders, Boston Scientific Corp. This ground-breaking device leverages state-of-the-art technology to not only monitor and regulate heart rhythm but also to provide life-saving defibrillation therapy.
The primary use of the CONTAK RENEWAL is to manage and treat ventricular and atrial cardiac arrhythmias. This addresses both fast and slow heart beat irregularities, effectively reducing the risk of sudden cardiac arrest and heart failure.
The device goes beyond just treatment and introduces a new era of proactive patient management. It comes armed with heart failure sensor technology, which collects data continuously to predict potential heart failure events in advance. This enables a more proactive approach to patient care, allowing medical professionals to act expediently in response to the person's health needs.
CONTAK RENEWAL is designed for patient comfort and practicability with a minimalistic and lightweight design that eases patient mobility and lifestyle adaptability. The device also offers a longer battery life, necessitating fewer device replacement procedures, and subsequently a better quality of life for the patient.
On the whole, CONTAK RENEWAL offers a harmonious blend of revolutionary design and leading-edge technology to improve the lives of patients with heart diseases. Its user-friendly design, coupled with its primary clinical benefits, make it a significant contributor to modern cardiac care.
Description:
The CONTAK RENEWAL 3 from Boston Scientific Corp. is an advanced Cardiac Resynchronization Therapy Defibrillator (CRT-D) device designed to assist in the management of patients struggling with moderate to severe heart failure.
This innovative device places emphasis on improving the synchronization of heart contractions by sending small electrical impulses to both lower chambers of the heart. This channel of stimulus helps to ensure the heart chambers contract at simultaneous intervals, enhancing overall heart function and patient wellbeing.
The CONTAK RENEWAL 3 also incorporates defibrillator functionality, giving it flexibility to detect and rectify any life-threatening ventricular arrhythmias. This dual capability serves to reassure patients that their heart rhythm is being closely managed, providing much needed security in situations of potential heart complications.
Noteworthy, this device avails remote patient monitoring capabilities, allowing patients' health to be tracked by their healthcare providers from a distance. This feature prioritizes patient comfort, convenience and lends itself towards proactive and timely management of the user's cardiac health.
Overall, the CONTAK RENEWAL 3 steps confidently into the realm of integrated cardiac health management, designed with patient safety, comfort and efficient heart performance in mind. Boston Scientific Corp. is dedicated to transforming lives through innovative medical solutions that bring about optimal health outcomes.
... Read moreDescription:
The CONTAK RENEWAL is an advanced cardiac resynchronization therapy defibrillator (CRT-D) developed by eminent medical manufacturer, Boston Scientific Corp. This state-of-the-art device is designed to monitor and control heart rhythm in patients with heart disease, combining cardiac resynchronization and defibrillatory therapies in a single unit.
Specifically, the CONTAK RENEWAL provides multi-site pacing and bi-ventricular pacing capabilities. This flexibility allows it to deliver therapy tailored to the individual patient's condition and needs. The device boasts high-energy defibrillation shocks for urgent cardiac events, alongside lower energy pacing impulses for the routine management of arrhythmias.
Key benefits of the CONTAK RENEWAL include its potential to improve exercise capacity, decrease heart failure hospitalizations, and enhance overall quality of life for its patients. Furthermore, the device is MRI compatible, providing safe and uninhibited access to important diagnostic procedures. With an impressive device longevity, the CONTAK RENEWAL ensures reliable performance over an extended service life.
With Boston Scientific's reputation for innovation and patient-focused design, the CONTAK RENEWAL represents a significant forward stride in cardiac care, providing clinicians with a powerful combination of technology and adaptability to customize treatments to patient needs.
... Read moreDescription:
The CONTAK RENEWAL Cardiac Resynchronization Therapy Defibrillator (CRT-D) is a state-of-the-art therapeutic system designed to provide electrical stimulation to the heart in patients with heart failure and to monitor and correct life-threatening cardiac arrhythmias. Made by Boston Scientific Corp., a global leader in medical technologies, the device is offered in several models to suit the individual needs of patients - H135, H170, H175, H177, and H179.
This pioneering multifunctional device combines the distinctive capabilities of a pacemaker and an implantable defibrillator. Its primary use is to slow down fast or irregular heart rhythms, to speed up slow heart rhythms, and to aid the heart chambers to beat in a more coordinated way - a benefit most essential for patients suffering from heart failure. With Cardiac Resynchronization Therapy (CRT), the device improves the efficiency of the heart, offers symptom management, and enhances the quality of life.
Moreover, the CONTAK RENEWAL CRT-D is designed with advanced monitoring features. It vigilantly tracks the heart rhythm and, in the case of a life-threatening arrhythmia, delivers a shock therapy to restore normal heart rhythm. It is thereby capable of preventing sudden cardiac death, providing patients with an extra layer of security and peace of mind.
With its cutting-edge technology, reliability, and patient-centered benefits, the CONTAK RENEWAL CRT-D offers a comprehensive solution for patients with heart failure and arrhythmia, contributing to better patient outcomes and promoting a healthier, more active lifestyle.
... Read moreDescription:
The CONTAK CD CONTAK RENEWAL EASYTRAK is an innovative medical device developed by Boston Scientific Corp. intended primarily for patients with severe heart conditions. This advanced device is specifically designed to detect profound cardiac conditions and deliver precise therapies when necessary.
The key strength of the CONTAK CD CONTAK RENEWAL EASYTRAK lies in its ability to offer both Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Implantable Cardioverter Defibrillator (ICD) components. The CRT-D device component works diligently to resynchronize the beating of the heart in patients with advanced heart failure symptoms, enhancing overall heart function and patient quality of life. Meanwhile, the ICD feature is crucial for patients at risk of sudden cardiac death, as it provides immediate response to life-threatening arrhythmias, potentially saving lives.
In addition, this device adapts to patient needs by providing advanced patient monitoring capabilities, allowing for encoded transmission of meaningful diagnostic information. It has a long-lasting battery life to ensure consistent performance and delivers therapy with minimal patient discomfort.
With its sophisticated capabilities, the CONTAK CD CONTAK RENEWAL EASYTRAK offers comprehensive cardiac care, bringing together convenience, peace of mind, and enhanced patient safety in one compact, high-technology device.
... Read more